DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
DRNA
Delisted
DRNA was delisted on the 27th of December, 2021.
103 hedge funds and large institutions have $622M invested in Dicerna Pharmaceuticals, Inc. in 2018 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 50 increasing their positions, 19 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
26% less capital invested
Capital invested by funds: $838M → $622M (-$216M)
Holders
103
Holding in Top 10
6
Calls
$133K
Puts
$1K
Top Buyers
| 1 | +$14.6M | |
| 2 | +$13.3M | |
| 3 | +$6.41M | |
| 4 |
RI
RTW Investments
New York
|
+$4.77M |
| 5 |
SCM
Sio Capital Management
New York
|
+$4.74M |
Top Sellers
| 1 | -$15.8M | |
| 2 | -$8.08M | |
| 3 | -$5.19M | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$2.98M |
| 5 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$2.87M |